Please Note- The efficacy of this product will vary depending upon the individual and their circumstances
For adult men (aged 18 years and over)
fficacy improved after the first dose in 60% of applications. There were 3,792 attempts and two-thirds (63%) of men achieved or exceeded the Minimal Clinically Important Difference (MCID).
